These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15178516)

  • 1. Regulatory issues in the approval of new drugs for diabetes mellitus, dyslipidemia, and the metabolic syndrome.
    Isaacsohn JL; Troendle AJ; Orloff DG
    Am J Cardiol; 2004 Jun; 93(11A):49C-52C. PubMed ID: 15178516
    [No Abstract]   [Full Text] [Related]  

  • 2. Free fatty acid receptor family: novel targets for the treatment of diabetes and dyslipidemia.
    Bernard J
    Curr Opin Investig Drugs; 2008 Oct; 9(10):1078-83. PubMed ID: 18821469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New developments in the treatment of diabetes and hyperlipidemias].
    Ducobu J
    Rev Med Brux; 1998 Sep; 19(4):A379-85. PubMed ID: 9805978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel diabetes drugs to face higher hurdles?
    Opar A
    Nat Rev Drug Discov; 2007 Sep; 6(9):687-9. PubMed ID: 17907340
    [No Abstract]   [Full Text] [Related]  

  • 5. American Diabetes Association--66th scientific sessions. Updates on drug treatments. 9-13 June 2006, Washington, DC, USA.
    Jago C
    IDrugs; 2006 Aug; 9(8):542-4. PubMed ID: 16871460
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug therapy in the heart transplant recipient: Part III: common medical problems.
    Lindenfeld J; Page RL; Zolty R; Shakar SF; Levi M; Lowes B; Wolfel EE; Miller GG
    Circulation; 2005 Jan; 111(1):113-7. PubMed ID: 15630040
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of atherogenic dyslipidemia of the metabolic syndrome: evolving rationale for combined drug therapy.
    Vega GL
    Endocrinol Metab Clin North Am; 2004 Sep; 33(3):525-44, vi. PubMed ID: 15262295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statement on fixed ratio combinations of drugs.
    Moss JM
    Va Med Mon (1918); 1971 Sep; 98(9):472-3. PubMed ID: 5119159
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS; Kashyap ML
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from the Avandia controversy: a new paradigm for the development of drugs to treat type 2 diabetes.
    Misbin RI
    Diabetes Care; 2007 Dec; 30(12):3141-4. PubMed ID: 18042753
    [No Abstract]   [Full Text] [Related]  

  • 11. New treatments for diabetes.
    Irony I; Parks MH; Meyer RJ
    N Engl J Med; 2007 May; 356(21):2221; author reply 2222-3. PubMed ID: 17526095
    [No Abstract]   [Full Text] [Related]  

  • 12. Normalization of metabolic syndrome using fenofibrate, metformin or their combination.
    Nieuwdorp M; Stroes ES; Kastelein JJ;
    Diabetes Obes Metab; 2007 Nov; 9(6):869-78. PubMed ID: 17924869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New treatments for diabetes.
    Raz I; Eldor R
    N Engl J Med; 2007 May; 356(21):2222; author reply 2222-3. PubMed ID: 17526096
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug development research: diabetes favored over cardiovascular disease?
    Suckling K
    Curr Opin Investig Drugs; 2009 Mar; 10(3):217-9. PubMed ID: 19333877
    [No Abstract]   [Full Text] [Related]  

  • 15. Dyslipidemia in type 2 diabetes.
    Krauss RM; Siri PW
    Med Clin North Am; 2004 Jul; 88(4):897-909, x. PubMed ID: 15308384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of pharmacologic agents for treatment of diabetes mellitus, dyslipidemia, and hypertension in children and adolescents.
    Daniels SR
    Arch Pediatr Adolesc Med; 2009 Apr; 163(4):389-91. PubMed ID: 19349572
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention and treatment of the metabolic syndrome in the elderly.
    Firdaus M
    J Okla State Med Assoc; 2005 Feb; 98(2):63-6. PubMed ID: 15789643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy.
    Segal JB; Dy SM; Millman EA; Herbert R; Bass EB; Wu A
    Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and treatment of metabolic syndrome in adolescents with type 2 diabetes.
    Sanders BH; Lubsch LM; West DS
    Ann Pharmacother; 2006 Sep; 40(9):1517-21. PubMed ID: 16896016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early pharmacological intervention in newly diagnosed metabolic syndrome and type 2 diabetes.
    Naruszewicz M
    Przegl Lek; 2006; 63 Suppl 4():7-8. PubMed ID: 16967707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.